Author:
Danquah Michael K.,Jeevanandam Jaison
Reference87 articles.
1. Facilitating the translation of nanomedicines to a clinical product: Challenges and opportunities;Agrahari;Drug Discovery Today,2018
2. The future application of nanomedicine and biomimicry in plastic and reconstructive surgery;Amin;Nanomedicine: Nanotechnology, Biology, and Medicine,2019
3. Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases;Anderson;Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology,2019
4. Phytosynthesized metal oxide nanoparticles for pharmaceutical applications;Andra;Naunyn-Schmiedeberg’s Archives of Pharmacology,2019
5. Ashok Bohara, R., Thorat, N., Thorat, N.D., Brennan, G., Bauer, J., Silien, C., & Tofail, S.A.M. (2019). Chapter 12: Strengths and limitations of translating the hybrid nanostructures to the clinic. In Hybrid nanostructures for cancer theranostics (pp. 229–254). Elsevier. Available from https://doi.org/10.1016/B978-0-12-813906-6.00012-3.